CETUXIMAB SAROTALOCAN
UNII U7S8ZU4L3M

Substance Identification & Data

This profile provides standardized clinical and technical data for Cetuximab Sarotalocan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U7S8ZU4L3M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U7S8ZU4L3M
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CETUXIMAB SAROTALOCAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10974
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cetuximab Sarotalocan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CETUXIMAB SAROTALOCAN

Common Names & Synonyms

CETUXIMAB SAROTALOCAN [INN]
CETUXIMAB SAROTALOCAN [USAN]
CETUXIMAB SAROTALOCAN [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR)(HUMAN- MOUSE MONOCLONAL C225 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL C225 .KAPPA.-CHAIN, DIMER, AMIDE WITH (OC-6-13)-(6-(((3-((29H,31H- PHTHALOCYANIN-1-YL-.KAPPA.N29,.KAPPA.N30,.KAPPA.N31,.KAPPA.N32)OXY)PROPOXY)CARBONYL)AMINO) HEXANOATO(2-))BIS(N-(3-((HYDROXY-.KAPPA.O)DIMETHYLSILYL)PROPYL)-3-SULFO-N,N-BIS(3- SULFOPROPYL)-1-PROPANAMINIUMATO(4-))SILICATE(4-)